Pharmafile Logo

adaptive trial design

- PMLiVE

Impactful Advances in Aesthetic Medicine

Medscape is pleased to announce new advancements within its Clinical Advances in Aesthetic Medicine. Launched in 2022, this initiative has effectively educated MD practitioners, showcasing measurable outcomes with submissions to...

Medscape Education

- PMLiVE

Experts issue call for new ‘toolbox’ to simplify early-phase clinical trial regulation in UK

The article outlines several recommendations to help improve early-phase clinical trials

Doctor speaking to patient and clinical setting in Cuttsy+Cuttsy branded shapes

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Cuttsy + Cuttsy

Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence

Dr. Javier Mendoza, Gastroenterologist and Digital Health Expert, explores digital health in medicine and clinical research, natural language processing, the ethics surrounding AI, and his experience as a medical doctor...

Impetus Digital

Blockchain in Healthcare: Predictions for the Post-COVID World

Dr. Jody Ranck, EVP, Global Strategy at Ram Global, discusses the novel ThEA diagnostic platform for rapid COVID-19 testing. He will also share his expertise on digital health, innovation, connected...

Impetus Digital

Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges

Jennifer Cox, Manager, Research Contracts at Ottawa Hospital Research Institute (OHRI), dives into the legal challenges associated with virtual trials, remote monitoring, digitalized patient info, and cross-border collaborations in the...

Impetus Digital

- PMLiVE

07 Good Pharma

Better for patients, better for business

Havas Lynx

EU flag

EU Parliament panel backs updated clinical trials regulations

But pharma industry concerned about measures to increase transparency

- PMLiVE

Clinical trial regulation in Mexico

Regulatory improvements make Mexico an appealing destination for clinical trials outsourcing

- PMLiVE

Adapt and overcome: Adaptive trial design in research

The pharma industry is slowly starting to embrace adaptive trial design, though not as quickly as once hoped, thanks largely to regulatory uncertainty

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links